Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William N. Kelley is active.

Publication


Featured researches published by William N. Kelley.


Science | 1967

Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis

J. Edwin Seegmiller; Frederick M. Rosenbloom; William N. Kelley

A sex-linked familial neurological disease consisting of cerebral palsy, mental retardation, choreoathetosis, and compulsive aggressive behavior is associated with a loss of an enzyme that participates in purine metabolism, namely, hypoxanthine-guanine phosphoribosyltransferase. The production of excessive uric acid in this disorder implies that the enzyme is involved in the normal regulation of purine biosynthesis. This is the first example of a relation between a specific enzyme defect and abnormal compulsive behavior. It is also the first enzyme defect in purine metabolism demonstrated in a neurological disease.


Annals of Internal Medicine | 1969

Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout

William N. Kelley; Martin L. Greene; Frederick M. Rosenbloom; J. Frank Henderson; J. E. Seegmiller

Excerpt INTRODUCTION Sophisticated biochemical studies in recent years have revealed that the regulation of intracellular metabolism is a logical, orderly, and intricate process. Control of enzyme ...


The New England Journal of Medicine | 1981

Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan Syndrome

Kenneth G. Lloyd; Oleh Hornykiewicz; Lynne Davidson; Katherine Shannak; Irene J. Farley; Menek Goldstein; Masato Shibuya; William N. Kelley; Irving H. Fox

Different brain regions were removed post mortem from three patients with the Lesch-Nyhan syndrome and were examined for alterations in hypoxanthine-guanine phosphoribosyl transferase (HGPRT), adenine phosphoribosyl transferase, and biochemical indexes of norepinephrine, dopamine, serotonin, gamma-aminobutyric acid (GABA), and acetylcholine neuron function, as compared with age-matched controls. The level of HGPRT activity in the material from patients with the Lesch-Nyhan syndrome was less than 1 per cent of control levels, whereas adenyl phosphoribosyl transferase was not significantly altered. All biochemical aspects of the function of dopamine-neuron terminals in the striatum (except dihydroxyphenylacetic acid levels) were decreased to 10 to 30 per cent of the control values. Serotonin and 5-hydroxyindoleacetic acid levels were increased, striatal choline acetyltransferase levels were low, and striatal glutamic acid decarboxylase and guanylate cyclase activities were unaltered. The disruption of the balance between the functions of GABA, dopamine, and acetylcholine neurons in the extrapyramidal system probably accounts for some of the symptoms observed in the Lesch-Nyhan syndrome (e.g., choreoathetosis).


Annals of Internal Medicine | 1971

Phosphoribosylpyrophosphate in Man: Biochemical and Clinical Significance

Irving H. Fox; William N. Kelley

Abstract The intracellular concentration of phosphoribosylpyrophosphate (PRPP), a high-energy 1,5-substituted ribose sugar, has been demonstrated to have a critical role in the regulation of purine...


Metabolism-clinical and Experimental | 1972

Studies on the mechanism of fructose-induced hyperuricemia in man

Irving H. Fox; William N. Kelley

The precise biochemical basis for many instances of hyperuricemia in man are not clearly understood. Elucidation of the mechanism by which certain normal intermediates and their structural analogs alter the serum uric acid may be useful in delineating potential pathophysiological alterations leading to hyperuricemia. The infusion of fructose in man precipitates a number of biochemical changes including hyperlacticacidemia, decrease in serum inorganic phosphate, and decrease in serum glucose. This results from the phosphorylation of fructose to fructose-1-P and the entrance of this compound into the glycolytic pathway. An increase in serum uric acid concentration following the infusion of fructose was initially reported by Perheentupa and Raivio in 1967., although this has remained a controversial observation.


Gene | 1989

Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector

Thomas D. Palella; Yuji Hidaka; Larry J. Silverman; Myron Levine; Joseph C. Glorioso; William N. Kelley

Complete deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) results in a devastating neurological disease, the Lesch-Nyhan syndrome. This disorder has been identified as a candidate for initial attempts at somatic cell gene therapy. We have previously reported the construction of a recombinant herpes simplex virus type 1 (HSV-1) vector containing human hprt cDNA sequences under the regulatory control of the viral thymidine kinase gene (tk) [Palella et al., Mol. Cell. Biol. 8 (1988) 457-460]. Infection of HPRT- cultured rat neuronal cells with these vectors resulted in transient expression of human hprt. In this paper, we report the expression of human hprt mRNA transcripts in the brains of mice infected in vivo with this vector by direct intracranial inoculation. Human hprt transcripts were distinguished from endogenous mouse transcripts by RNase A mapping using riboprobes transcribed from human hprt cDNA. These initial studies demonstrate the transfer and transcription of a human gene in brain cells by direct in vivo infection with recombinant HSV-1 vectors.


Journal of Clinical Investigation | 1976

A role for adenosine deaminase in human monocyte maturation.

Dina G. Fischer; M B Van der Weyden; Ralph Snyderman; William N. Kelley

The occurrence of a deficiency of adenosine deaminase (ADA) activity in some patients with severe combined immunodeficiency suggests a possible relationship between the activity of ADA and the aberration of the immune system. To help delineate the function of ADA in the immune response we have examined its role in monocyte maturation. When incubated in vitro, peripheral blood monocytes transformed, within 3 days, to macrophagea as assessed by phase-contrast microscopy and an increase in the specific activity of the lysosomal enzyme acid phosphatase. The specific activity of ADA increased as much as ninefold, reaching a peak after the 1st day in culture, while the activities of other enzymes involved in the purine salvage pathway were not altered. Sucrose density ultracentrifugation of extracts prepared immediately after the isolation of monocytes revealed the presence of two forms of ADA with molecular weights of approximately 30,000 and 110,000. The increase in ADA specific activity during monocyte cultivation correlated with an increase in the activity of the smaller molecular species. A specific inhibitor ADA, erythro-9-(2-hydroxy-3-nonyl) adenine, prevented the increase in acid phosphatase activity, as well as the morphological changes associated with the monocyte maturation. These data suggest a role for ADA in monocyte to macrophage maturation. In view of the central role of macrophages in immune function, this observation may relate to the association of combined immunodeficiency and a deficiency of this enzyme.


Analytical Biochemistry | 1974

Measurement of DNA in cultured human cells

Albert Leyva; William N. Kelley

Abstract A simple microtechnique has been developed for the accurate determination of DNA in less than 1 × 10 6 cultured human fibroblasts or lymphoblasts. This technique involves rapid separation of DNA from the cell extract supernatant and from the extraction buffer in order to avoid interference with the colorimetric diphenylamine assay. The method described does not involve complicated manipulation of samples and does not require special instrumentation. In addition, multiple samples can be conveniently prepared to be assayed at a later time and various other biochemical determinations such as enzyme assays can be done on soluble extracts of the same cell samples.


Journal of Clinical Investigation | 1968

Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man

William N. Kelley; Robert I. Levy; Frederick M. Rosenbloom; J. Frank Henderson; J. Edwin Seegmiller

A deficiency of adenine phosphoribosyltransferase (A-PRTase) is described in four members in three generations of one family. A-PRTase is coded by an autosome and the mutants described in this report are heterozygotes for this enzyme defect. The level of enzyme activity in these heterozygotes was inappropriately low, ranging from 21 to 37% of normal rather than the expected 50% of normal. Examination of various physical and chemical properties of the A-PRTase obtained from the mutant heterozygotes failed to reveal differences from the normal enzyme. These patients have no discernable abnormality in uric acid production despite the finding that patients with a deficiency of a closely related enzyme, hypoxanthine-guanine phosphoribosyltransferase, invariably produce excessive quantities of uric acid. A relationship of the A-PRTase deficiency to the disturbance in lipoprotein metabolism observed in the propositus has not been firmly established. Possible manifestations of the homozygous form of this enzyme deficiency will require identification of such individuals in the future.


Molecular and Cellular Biology | 1988

Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.

Thomas D. Palella; Larry J. Silverman; C T Schroll; F. L. Homa; Myron Levine; William N. Kelley

The virtually complete deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) results in a devastating neurological disease, Lesch-Nyhan syndrome. Transfer of the HPRT gene into fibroblasts and lymphoblasts in vitro and into hematopoietic cells in vivo has been accomplished by other groups with retroviral-derived vectors. It appears to be necessary, however, to transfer the HPRT gene into neuronal cells to correct the neurological dysfunction of this disorder. The neurotropic virus herpes simplex virus type 1 has features that make it suitable for use as a vector to transfer the HPRT gene into neuronal tissue. This report describes the isolation of an HPRT-deficient rat neuroma cell line, designated B103-4C, and the construction of a recombinant herpes simplex virus type 1 that contained human HPRT cDNA. These recombinant viruses were used to infect B103-4C cells. Infected cells expressed HPRT activity which was human in origin.

Collaboration


Dive into the William N. Kelley's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James M. Wilson

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Beverly L. Davidson

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James B. Wyngaarden

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge